Application 022100

Type
NDA
Sponsor
DAIICHI SANKYO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AZORAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILTABLET;ORALEQ 5MG BASE;20MGYesNo
002AZORAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILTABLET;ORALEQ 5MG BASE;40MGYesNo
003AZORAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILTABLET;ORALEQ 10MG BASE;20MGYesNo
004AZORAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILTABLET;ORALEQ 10MG BASE;40MGYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N022100-001AZORAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILEQ 5MG BASE;20MGTABLET / ORALABRLD2007-09-26
N022100-002AZORAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILEQ 5MG BASE;40MGTABLET / ORALABRLD2007-09-26
N022100-003AZORAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILEQ 10MG BASE;20MGTABLET / ORALABRLD2007-09-26
N022100-004AZORAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILEQ 10MG BASE;40MGTABLET / ORALABRLD, RS2007-09-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
N022100-001AB
N022100-002AB
N022100-003AB
N022100-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N022100-001AZOREQ 5MG BASE;20MGTABLET / ORALABRLD2007-09-2684e616aacf4f…
2026-09-14 22:38:342026-08N022100-002AZOREQ 5MG BASE;40MGTABLET / ORALABRLD2007-09-2684e616aacf4f…
2026-09-14 22:38:342026-08N022100-003AZOREQ 10MG BASE;20MGTABLET / ORALABRLD2007-09-2684e616aacf4f…
2026-09-14 22:38:342026-08N022100-004AZOREQ 10MG BASE;40MGTABLET / ORALABRLD, RS2007-09-2684e616aacf4f…
2026-08-18 06:07:402026-07N022100-001AZOREQ 5MG BASE;20MGTABLET / ORALABRLD2007-09-26caaa826d4ba7…
2026-08-18 06:07:402026-07N022100-002AZOREQ 5MG BASE;40MGTABLET / ORALABRLD2007-09-26caaa826d4ba7…
2026-08-18 06:07:402026-07N022100-003AZOREQ 10MG BASE;20MGTABLET / ORALABRLD2007-09-26caaa826d4ba7…
2026-08-18 06:07:402026-07N022100-004AZOREQ 10MG BASE;40MGTABLET / ORALABRLD, RS2007-09-26caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N022100-001AZOREQ 5MG BASE;20MGTABLET / ORALABRLD2007-09-26011fe1cb6892…
2026-02-19 14:30 UTC2026-02N022100-002AZOREQ 5MG BASE;40MGTABLET / ORALABRLD2007-09-26011fe1cb6892…
2026-02-19 14:30 UTC2026-02N022100-003AZOREQ 10MG BASE;20MGTABLET / ORALABRLD2007-09-26011fe1cb6892…
2026-02-19 14:30 UTC2026-02N022100-004AZOREQ 10MG BASE;40MGTABLET / ORALABRLD, RS2007-09-26011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022100-001AZOREQ 5MG BASE;20MGTABLET / ORALABRLD2007-09-2631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022100-002AZOREQ 5MG BASE;40MGTABLET / ORALABRLD2007-09-2631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022100-003AZOREQ 10MG BASE;20MGTABLET / ORALABRLD2007-09-2631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022100-004AZOREQ 10MG BASE;40MGTABLET / ORALABRLD, RS2007-09-2631067a03dcf5…
2025-08-23 18:47 UTC2025-08N022100-001AZOREQ 5MG BASE;20MGTABLET / ORALABRLD2007-09-266a471c1ec25d…
2025-08-23 18:47 UTC2025-08N022100-002AZOREQ 5MG BASE;40MGTABLET / ORALABRLD2007-09-266a471c1ec25d…
2025-08-23 18:47 UTC2025-08N022100-003AZOREQ 10MG BASE;20MGTABLET / ORALABRLD2007-09-266a471c1ec25d…
2025-08-23 18:47 UTC2025-08N022100-004AZOREQ 10MG BASE;40MGTABLET / ORALABRLD, RS2007-09-266a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022100-001AZOREQ 5MG BASE;20MGTABLET / ORALABRLD2007-09-26fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022100-002AZOREQ 5MG BASE;40MGTABLET / ORALABRLD2007-09-26fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022100-003AZOREQ 10MG BASE;20MGTABLET / ORALABRLD2007-09-26fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022100-004AZOREQ 10MG BASE;40MGTABLET / ORALABRLD, RS2007-09-26fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022100-001AZOREQ 5MG BASE;20MGTABLET / ORALABRLD2007-09-26b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022100-002AZOREQ 5MG BASE;40MGTABLET / ORALABRLD2007-09-26b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022100-003AZOREQ 10MG BASE;20MGTABLET / ORALABRLD2007-09-26b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022100-004AZOREQ 10MG BASE;40MGTABLET / ORALABRLD, RS2007-09-26b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022100-001AZOREQ 5MG BASE;20MGTABLET / ORALABRLD2007-09-2603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022100-002AZOREQ 5MG BASE;40MGTABLET / ORALABRLD2007-09-2603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022100-003AZOREQ 10MG BASE;20MGTABLET / ORALABRLD2007-09-2603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022100-004AZOREQ 10MG BASE;40MGTABLET / ORALABRLD, RS2007-09-2603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022100-001AZOREQ 5MG BASE;20MGTABLET / ORALABRLD2007-09-262680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022100-002AZOREQ 5MG BASE;40MGTABLET / ORALABRLD2007-09-262680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022100-003AZOREQ 10MG BASE;20MGTABLET / ORALABRLD2007-09-262680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022100-004AZOREQ 10MG BASE;40MGTABLET / ORALABRLD, RS2007-09-262680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022100-001AZOREQ 5MG BASE;20MGTABLET / ORALABRLD2007-09-265bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022100-002AZOREQ 5MG BASE;40MGTABLET / ORALABRLD2007-09-265bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022100-003AZOREQ 10MG BASE;20MGTABLET / ORALABRLD2007-09-265bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022100-004AZOREQ 10MG BASE;40MGTABLET / ORALABRLD, RS2007-09-265bbf6a4d5a75…

Observed Orange Book normalized TE history#

Normalized TE history page 2 of 5 · 172 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022100-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022100-002AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022100-003AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022100-004AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N022100-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10N022100-002AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10N022100-003AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10N022100-004AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022100-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022100-002AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022100-003AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022100-004AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N022100-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N022100-002AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N022100-003AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N022100-004AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N022100-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N022100-002AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N022100-003AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N022100-004AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N022100-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N022100-002AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N022100-003AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N022100-004AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N022100-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N022100-002AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N022100-003AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N022100-004AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N022100-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N022100-002AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N022100-003AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N022100-004AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N022100-001AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N022100-002AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N022100-003AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N022100-004AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N022100-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N022100-002AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N022100-003AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N022100-004AB174a2ff9319b5…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
amlodipine besylate and olmesartan medoxomilAMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMILGolden State Medical Supply, Inc.132cca8f-48a2-2516-e063-6394a90a5f322026-04-28Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 022100
application number: NDA022100
AzorAMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMILCosette Pharmaceuticals, Inc.c5535406-b63b-49aa-88b9-169aaf0ed08e2023-07-12Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 022100
application number: NDA022100
ndc (product): 0713-0872
ndc (product): 0713-0871
ndc (product): 0713-0873
ndc (product): 0713-0870

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 56 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0713-0870Azoramlodipine besylate and olmesartan medoxomilCosette Pharmaceuticals, Inc.NDACurrent
0713-0870Azoramlodipine besylate and olmesartan medoxomilCosette Pharmaceuticals, Inc.NDACurrent
0713-0870Azoramlodipine besylate and olmesartan medoxomilCosette Pharmaceuticals, Inc.NDACurrent
0713-0871Azoramlodipine besylate and olmesartan medoxomilCosette Pharmaceuticals, Inc.NDACurrent
0713-0871Azoramlodipine besylate and olmesartan medoxomilCosette Pharmaceuticals, Inc.NDACurrent
0713-0871Azoramlodipine besylate and olmesartan medoxomilCosette Pharmaceuticals, Inc.NDACurrent
0713-0872Azoramlodipine besylate and olmesartan medoxomilCosette Pharmaceuticals, Inc.NDACurrent
0713-0872Azoramlodipine besylate and olmesartan medoxomilCosette Pharmaceuticals, Inc.NDACurrent
0713-0872Azoramlodipine besylate and olmesartan medoxomilCosette Pharmaceuticals, Inc.NDACurrent
0713-0873Azoramlodipine besylate and olmesartan medoxomilCosette Pharmaceuticals, Inc.NDACurrent
0713-0873Azoramlodipine besylate and olmesartan medoxomilCosette Pharmaceuticals, Inc.NDACurrent
0713-0873Azoramlodipine besylate and olmesartan medoxomilCosette Pharmaceuticals, Inc.NDACurrent
57664-772Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-772Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-772Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-772Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-772Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-773Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-773Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-773Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-773Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-773Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-774Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-774Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-774Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-774Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-774Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-775Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-775Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-775Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-775Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
57664-775Amlodipine and Olmesartan Medoxomilamlodipine besylate and olmesartan medoxomilSun Pharmaceutical Industries, Inc.NDACurrent
65597-110Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-110Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-110Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-110Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-110Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-110Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-111Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-111Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-111Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-111Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-111Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-111Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-112Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-112Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-112Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-112Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-112Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-112Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-113Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-113Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-113Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-113Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-113Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent
65597-113Azoramlodipine besylate and olmesartan medoxomilDaiichi Sankyo Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
64874SUPPL2020-10-07
64819SUPPL2020-10-05
46836SUPPL2017-01-13
46723SUPPL2017-01-06
46132SUPPL2016-12-13
45779SUPPL2016-11-02
45775SUPPL2016-11-01
16929SUPPL2014-09-26
6875SUPPL2014-09-24
38230SUPPL2014-07-03
6874SUPPL2014-07-03
6873SUPPL2014-06-18
38229SUPPL2014-06-17
38228SUPPL2013-07-05
6872SUPPL2013-07-05
38227SUPPL2012-12-13
6871SUPPL2012-12-11
29235SUPPL2012-10-03
16928SUPPL2012-10-02
38226SUPPL2012-01-23
29234SUPPL2012-01-20
29232SUPPL2011-11-16
38224SUPPL2011-11-14
29233SUPPL2011-11-03
38225SUPPL2011-10-31
6870SUPPL2011-05-24
6869SUPPL2011-05-24
38223SUPPL2011-05-23
16927SUPPL2011-05-23
21935ORIG2009-12-17
29230SUPPL2009-05-14
38222SUPPL2009-05-13
29231SUPPL2008-08-12
38221ORIG2007-10-04
6868ORIG2007-10-04